SCHEMBL3970031

SCHEMBL3970031

CCCCCCCCCCCCOCCCCCCCCCCCCCOC(Oc1ccc(-c2nc(-c3ccc(-c4ccccc4)cc3)nc(-c3ccc(-c4ccccc4)cc3)n2)c(O)c1)C(C)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.39
PTPN11 Q06124 3/20 0.39
CNR2 P34972 1/20 0.39
PLK1 P53350 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PPARG P37231 2/20 0.35
PLA2G4B P0C869 1/20 0.35
PPARA Q07869 1/20 0.35
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
NCOR2 Q9Y618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7153091 0.85 CYP2C19 (0.40) CNR2CYP3A4CYP2C9CYP2C19PLA2G4B
SCHEMBL38879 0.84 PLK1 (0.39) RARBPTPN11CNR2PLK1THRA
SCHEMBL30787100 0.84 RARB (0.43) RARBPTPN11CNR2PLK1THRA
SCHEMBL7114762 0.83 CNR2 (0.36) PTPN11CNR2PPARGPLA2G4BPPARA
SCHEMBL4581126 0.81 ADORA3 (0.39) PTPN11CNR2TSHR
SCHEMBL887949 0.81 CNR2 (0.46) RARBPTPN11CNR2CYP2C9CYP2C19
SCHEMBL16985037 0.81 CNR2 (0.46) RARBPTPN11CNR2CYP2C9CYP2C19
SCHEMBL29353180 0.81 CNR2 (0.46) RARBPTPN11CNR2CYP2C9CYP2C19
SCHEMBL5081657 0.81 PLK1 (0.40) PTPN11CNR2PLK1PPARGPLA2G4B
SCHEMBL10090875 0.81 PTPN11 (0.52) RARBPTPN11CNR2TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476699-B2 Amino- and hydroxysubstituted triphenyl-s-triazines as stabilizers CIBA SPECIALTY CHEMICALS CORP. (US) 2009-01-13 US disclosed
US-20070274933-A1 Amino- and hydroxysubstituted triphenyl-S-triazines as stabilizers REINEHR DIETER 2007-11-29 US disclosed
US-20040049052-A1 Benzophenone uv-absorbers with heterocyclic substituents CIBA SPECIALTY CHEMICALS CORP. 2004-03-11 US disclosed
EP-1351943-A1 BENZOPHENONE UV-ABSORBERS WITH HETEROCYCLIC SUBSTITUENTS Ciba SC Holding AG (CH) 2003-10-15 EP disclosed
EP-1021421-B1 AMINO- AND HYDROXYSUBSTITUTED TRIPHENYL-S-TRIAZINES AS STABILIZERS CIBA SC HOLDING AG (CH) 2003-10-01 EP disclosed
EP-1322640-A1 HETEROARYL SUBSTITUTED HYDROXYPHENYLTRIAZINE UV-ABSORBERS Ciba SC Holding AG (CH) 2003-07-02 EP disclosed
US-20020165298-A1 Amino- and hydroxysubstituted triphenyl-s-triazines as stabilizers REINEHR DIETER (DE) 2002-11-07 US disclosed
WO-2002048118-A1 BENZOPHENONE UV-ABSORBERS WITH HETEROCYCLIC SUBSTITUENTS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-06-20 WO disclosed
WO-2002028854-A1 HETEROARYL SUBSTITUTED HYDROXYPHENYLTRIAZINE UV-ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-04-11 WO disclosed
EP-1021421-A1 AMINO- AND HYDROXYSUBSTITUTED TRIPHENYL-S-TRIAZINES AS STABILIZERS Ciba SC Holding AG (CH) 2000-07-26 EP disclosed
WO-1997036880-A1 AMINO- AND HYDROXYSUBSTITUTED TRIPHENYL-S-TRIAZINES AS STABILIZERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1997-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040049052-A1 Benzophenone uv-absorbers with heterocyclic substituents TRPC1, C1S, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 RARB 2822/4885PTPN11 4664/4885CNR2 465/4885
US-20070274933-A1 Amino- and hydroxysubstituted triphenyl-S-triazines as stabilizers AHR, HRH4, HRH2 RARB 2933/4885PTPN11 2768/4885CNR2 105/4885
US-20020165298-A1 Amino- and hydroxysubstituted triphenyl-s-triazines as stabilizers CCNL2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR RARB 2807/4885PTPN11 2968/4885CNR2 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.